Skip to content

    Cancer Health Center

    Font Size
    A
    A
    A

    Late Effects of Treatment for Childhood Cancer (PDQ®): Treatment - Health Professional Information [NCI] - Late Effects of the Endocrine System

    continued...

    During childhood and adolescence, there is an increased incidence of developing thyroid nodules, and potentially, thyroid cancer for patients exposed to iodine I 131 metaiodobenzylguanidine (131 I-mIBG). Children who have been treated with 131 I-mIBG should undergo lifelong monitoring, not only for thyroid function but also for the development of thyroid nodules and thyroid cancer.[14]

    Several investigations have demonstrated the superiority of ultrasound to clinical exam for detecting thyroid nodules/cancers and characterized ultrasonographic features of nodules that are more likely to be malignant.[15,16] However, primary screening for thyroid neoplasia (beyond physical exam with thyroid palpation) remains controversial because of the lack of data indicating a survival benefit and quality-of-life benefit associated with early detection and intervention. In fact, because these lesions tend to be indolent, are rarely life-threatening, and may clinically manifest many years after exposure to radiation, there are significant concerns regarding the costs and harms of overscreening.[17]

    (Refer to the Subsequent Neoplasms section of this summary for information about subsequent thyroid cancers.)

    Posttransplant thyroid dysfunction

    Survivors of pediatric hematopoietic stem cell transplant are at increased risk of thyroid dysfunction, with the risk being much lower (15%-16%) after fractionated total-body irradiation (TBI), as opposed to single-dose TBI (46%-48%). Non-TBI-containing regimens historically were not associated with an increased risk. However, in a report from the Fred Hutchinson Cancer Research Center, the increased risk of thyroid dysfunction was not different between children receiving a TBI or busulfan-based regimen (P = .48).[18] Other high-dose therapies have not been studied. While mildly elevated TSH is common, it is usually accompanied by normal thyroxine concentration.[19,20]

    Table 7. Thyroid Late Effects

    Predisposing Therapy Endocrine/Metabolic Effects Health Screening
    mIBG = metaiodobenzylguanidine; TSH = thyroid stimulating hormone.
    Radiation impacting thyroid gland; thyroidectomy Primary hypothyroidism TSH level
    Radiation impacting thyroid gland Hyperthyroidism Free thyroxine (Free T4) level
    TSH level
    Radiation impacting thyroid gland, including mIBG Thyroid nodules Thyroid exam
    Thyroid ultrasound

    Central hypothyroidism is discussed with late effects that affect the pituitary gland.

    Pituitary Gland

    Survivors of childhood cancer are at risk for a spectrum of neuroendocrine abnormalities, primarily due to the effect of radiation therapy on the hypothalamus. Essentially all of the hypothalamic-pituitary axes are at risk.[21,22,23] The six anterior pituitary hormones and their major hypothalamic regulatory factors are outlined in Table 8.

    1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12
    1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12
    Next Article:

    Today on WebMD

    Colorectal cancer cells
    New! I AM Not Cancer Facebook Group
    Lung cancer xray
    See it in pictures, plus read the facts.
     
    sauteed cherry tomatoes
    Fight cancer one plate at a time.
    Ovarian cancer illustration
    Real Cancer Perspectives
     
    Jennifer Goodman Linn self-portrait
    Blog
    what is your cancer risk
    HEALTH CHECK
     
    colorectal cancer treatment advances
    Video
    breast cancer overview slideshow
    SLIDESHOW
     
    prostate cancer overview
    SLIDESHOW
    lung cancer overview slideshow
    SLIDESHOW
     
    ovarian cancer overview slideshow
    SLIDESHOW
    Actor Michael Douglas
    Article